WAY-630998 is primarily used in scientific research as a potent and selective agonist for the GPR139 receptor, a G-protein-coupled receptor expressed in the brain. Its main application lies in neuropharmacological studies, where it helps investigate the role of GPR139 in modulating neurotransmitter systems, particularly those involving dopamine and glutamate. Researchers use WAY-630998 to explore potential pathways related to psychiatric and neurological disorders such as schizophrenia, depression, and Parkinson’s disease. Due to its selectivity, it serves as a valuable tool compound for validating GPR139 as a therapeutic target and for understanding downstream signaling mechanisms in cellular and animal models. It is not used clinically and remains restricted to preclinical research settings.